Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,589 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Haemophagocytic lymphohistiocytosis in pregnancy.
Jawad S, Dhariwal A, Ellis L, Cosgrove C, Reyal Y. Jawad S, et al. Among authors: ellis l. Lancet Haematol. 2020 Jun;7(6):e498. doi: 10.1016/S2352-3026(20)30101-0. Lancet Haematol. 2020. PMID: 32470441 No abstract available.
Efficacy and tolerability of VCD chemotherapy in a UK real-world dataset of elderly transplant-ineligible newly diagnosed myeloma patients.
Rampotas A, Djebbari F, Panitsas F, Lees C, Tsagkaraki I, Gomes AR, Prideaux S, Chen L, Prodger C, Khera A, Gray N, Ellis L, Sangha G, Lim WY, Eyre TA, Moore S, Ramasamy K, Kothari J. Rampotas A, et al. Among authors: ellis l. Eur J Haematol. 2021 Apr;106(4):563-573. doi: 10.1111/ejh.13588. Epub 2021 Feb 5. Eur J Haematol. 2021. PMID: 33496996
Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.
Djebbari F, Rampotas A, Panitsas F, Lim WY, Lees C, Tsagkaraki I, Gomes AR, Prideaux S, Chen L, Prodger C, Khera A, Gray N, Ellis L, Sangha G, Eyre TA, Moore S, Kothari J, Ramasamy K. Djebbari F, et al. Among authors: ellis l. PLoS One. 2022 Jan 11;17(1):e0262388. doi: 10.1371/journal.pone.0262388. eCollection 2022. PLoS One. 2022. PMID: 35015781 Free PMC article.
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations.
Russell NH, Wilhelm-Benartzi C, Othman J, Dillon R, Knapper S, Batten LM, Canham J, Hinson EL, Betteridge S, Overgaard UM, Gilkes A, Potter N, Mehta P, Kottaridis P, Cavenagh J, Hemmaway C, Arnold C, Freeman SD, Dennis M; PORTEC Study Group. Russell NH, et al. J Clin Oncol. 2024 Apr 1;42(10):1158-1168. doi: 10.1200/JCO.23.00943. Epub 2024 Jan 12. J Clin Oncol. 2024. PMID: 38215358 Clinical Trial.
Individualised care for cervical precancer.
Paraskevaidis E, Athanasiou A, Ellis LB, Bowden SJ, Kyrgiou M. Paraskevaidis E, et al. Among authors: ellis lb. BMJ. 2025 Jan 17;388:r7. doi: 10.1136/bmj.r7. BMJ. 2025. PMID: 39824606 No abstract available.
Adopting public health genomics when the house is on fire: How will we navigate to 2030?
Braithwaite J, Spanos S, Lamprell K, Vizheh M, Sheriff S, Fisher G, Pagano L, Ellis LA, Churruca K, Patel R, Taylor N, Best S, Long JC. Braithwaite J, et al. Among authors: ellis la. Public Health Genomics. 2025 Jan 2:1-21. doi: 10.1159/000543161. Online ahead of print. Public Health Genomics. 2025. PMID: 39746335 Free article. No abstract available.
1,589 results